Ophthalmology

Ohr Pharmaceutical to pay $3.5 million up front for tech platform and preclinical candidates

Lead ophthalmic product features company’s proprietary mucus penetrating particle platform

Interim results show improvement in visual function and slowing of disease progression following stem cell transplantation in Phase 1/2 dry AMD trial

Mice with MS-like virus recover after human stem cell injections, offering hope for human cure

Sun Pharmaceutical to acquire rival Ranbaxy Laboratories for $3.2 billion

Avalanche could receive up to $640 million in contingent payments if all milestones are met

Sun Pharma believes it can fix problems that have caused big problems for Ranbaxy Laboratories’ current controlling shareholder, Japan's Daiichi Sankyo

Short-strand RNAs demonstrate positive results in animal models as a possible treatment for eye disease, blindness

Fibromyalgia study shows reduction in pain; diabetic peripheral neuropathy misses the mark

WITec’s RayShield Coupler is now available for the alpha300 and alpha500 microscope series.

UniFORM is an application that streamlines other business applications into one.

Aggressive acquisition strategy continues with latest transaction, which will establish Valeant as a leader in ophthalmology